The Boss isn’t the only one suffering from peptic ulcer disease.
Turns out, up to 10% of the global population — including more than 4 million Americans a year — suffer from the often painful digestive disorder. And it runs up an estimated $10 billion annual tab for both direct and indirect healthcare costs, according to the American Academy of Family Physicians. In fact, the global peptic ulcer drugs market was valued at $4.25 billion in 2019, according to Fortune Business Insights, and it is projected to reach $5.13 billion…
Read the full article here
